MTT Trademark

Trademark Overview

On Wednesday, December 30, 2020, a trademark application was filed for MTT with the United States Patent and Trademark Office. The USPTO has given the MTT trademark a serial number of 90432097. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, May 19, 2025. This trademark is owned by Alphyn Biologics, LLC. The MTT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
mtt

General Information

Serial Number90432097
Word MarkMTT
Filing DateWednesday, December 30, 2020
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, May 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and ServicesResearch and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 24, 2021
Primary Code042
First Use Anywhere DateWednesday, August 21, 2024
First Use In Commerce DateWednesday, August 21, 2024

Trademark Owner History

Party NameALPHYN BIOLOGICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressAnnapolis, MD 21403
Party NameAlphyn Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAnnapolis, MD 21403
Party NameAlphyn Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAnnapolis, MD 21403

Trademark Events

Event DateEvent Description
Wednesday, June 30, 2021ASSIGNED TO EXAMINER
Saturday, January 2, 2021NEW APPLICATION ENTERED
Wednesday, March 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 12, 2021NON-FINAL ACTION WRITTEN
Monday, July 12, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 17, 2022SOU EXTENSION 1 FILED
Thursday, November 17, 2022SOU EXTENSION 1 GRANTED
Saturday, November 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 12, 2023SOU EXTENSION 2 FILED
Friday, May 12, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024SOU EXTENSION 4 FILED
Tuesday, April 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, December 26, 2024SOU EXTENSION 5 GRANTED
Thursday, November 16, 2023SOU EXTENSION 3 FILED
Thursday, November 16, 2023SOU EXTENSION 3 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 13, 2024SOU EXTENSION 5 FILED
Thursday, December 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 15, 2025USE AMENDMENT FILED
Friday, May 16, 2025TEAS STATEMENT OF USE RECEIVED
Sunday, May 18, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

research diseases development biomedicine fields scientific analysis testing pharmaceutical life